IMTX
Price
$9.92
Change
+$0.09 (+0.92%)
Updated
Jan 15 closing price
Capitalization
1.33B
68 days until earnings call
Intraday BUY SELL Signals
SLN
Price
$5.56
Change
-$0.31 (-5.28%)
Updated
Jan 15 closing price
Capitalization
170.04M
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMTX vs SLN

Header iconIMTX vs SLN Comparison
Open Charts IMTX vs SLNBanner chart's image
Immatics
Price$9.92
Change+$0.09 (+0.92%)
Volume$311.59K
Capitalization1.33B
Silence Therapeutics
Price$5.56
Change-$0.31 (-5.28%)
Volume$211.98K
Capitalization170.04M
IMTX vs SLN Comparison Chart in %
IMTX
Daily Signal:
Gain/Loss:
SLN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMTX vs. SLN commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (IMTX: $9.83 vs. SLN: $5.87)
Brand notoriety: IMTX and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 69% vs. SLN: 123%
Market capitalization -- IMTX: $1.33B vs. SLN: $170.04M
IMTX [@Biotechnology] is valued at $1.33B. SLN’s [@Biotechnology] market capitalization is $170.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMTX and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 3 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • IMTX’s TA Score: 3 bullish, 6 bearish.
  • SLN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SLN is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а -0.10% price change this week, while SLN (@Biotechnology) price change was +1.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

IMTX is expected to report earnings on Mar 25, 2026.

SLN is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.33B) has a higher market cap than SLN($170M). IMTX YTD gains are higher at: -5.524 vs. SLN (-8.553). SLN has higher annual earnings (EBITDA): -81.06M vs. IMTX (-106.34M). IMTX has more cash in the bank: 431M vs. SLN (102M). SLN has less debt than IMTX: SLN (182K) vs IMTX (16.4M). IMTX has higher revenues than SLN: IMTX (84.8M) vs SLN (25.8M).
IMTXSLNIMTX / SLN
Capitalization1.33B170M782%
EBITDA-106.34M-81.06M131%
Gain YTD-5.524-8.55365%
P/E Ratio27.61N/A-
Revenue84.8M25.8M329%
Total Cash431M102M423%
Total Debt16.4M182K9,011%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMTXSLN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signal:
Gain/Loss:
SLN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALFFF0.96N/A
N/A
Alfa S.A.B de C.V
JAXAF0.04N/A
N/A
VINYL GROUP LTD.
NTPR0.26N/A
N/A
NutraProducts Inc.
RNECF15.50N/A
N/A
Renesas Electronics Corp
CLRPF2.25-0.17
-7.02%
Clarity Pharmaceuticals Ltd.

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.92%
IDYA - IMTX
54%
Loosely correlated
-2.62%
XNCR - IMTX
49%
Loosely correlated
-8.58%
VYGR - IMTX
49%
Loosely correlated
-7.51%
VIR - IMTX
49%
Loosely correlated
-9.09%
KURA - IMTX
49%
Loosely correlated
-4.81%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-5.28%
CLLS - SLN
43%
Loosely correlated
-4.33%
CMVLF - SLN
38%
Loosely correlated
N/A
TSHA - SLN
38%
Loosely correlated
-2.78%
PCVX - SLN
36%
Loosely correlated
-0.97%
IMTX - SLN
36%
Loosely correlated
+0.92%
More